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Abstract 
 Developmental duplications (DD) is a genetic condition recently characterized in Angus 
cattle. It is a congenital abnormality where duplication of neural crest derived tissues occurs 
during embryonic development. A common phenotypic presentation of the condition includes 
calves born with polymelia most frequently involving duplication of the front limbs that protrude 
from the neck or shoulder region. Aside from polymelia, DD affected individuals present 
malformations associated with neural tube defects (NTDs). Genome-wide association studies 
have identified a single locus associated with this disease phenotype. Further investigation has 
identified the putative mutation as a nonsynonymous substitution (p.Val311Ala) in the NHL 
repeat-containing 2 (NHLRC2) gene. Transcription activator-like effector nucleases (TALENs) 
targeting exon 5 of NHLRC2 were used for gene-editing of the orthologous locus in mice to 
further investigate the role of NHLRC2 in development. Three mouse lines were generated with 
mutations having varying impacts on the NHLRC2 protein. Two mutations, -2 bp and -19 bp, are 
predicted to cause a prematurely truncated protein and one mutation, -12 bp, the deletion of four 
amino acids, residues 307 through 310, adjacent to the corresponding bovine substitution. 
Heterozygous mice of each line were intermated to phenotypically characterize homozygous 
progeny. Genotyping of the offspring revealed absence of homozygous individuals suggesting 
embryonic lethality. Because initiation of neural tube closure in mice occurs at day E8.5, 
embryonic death was assessed at this developmental day by harvesting embryos from 
heterozygous matings at day E8.5 with subsequent genotyping. Again, no homozygous embryos 
could be detected, however yolk sacs containing no embryos were observed. Furthermore, the 
number of yolk sacs exceeded the average number of live births by 68% (11.3 vs. 6.7), indicating 
embryonic lethality of homozygous individuals most likely occurs between fertilization and 
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E8.5. Thus, we suggest that NHLRC2 is essential during mammalian development and 
hypothesize NHLRC2 plays a significant role in neurulation.  
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Chapter 1: Literature Review 
1.1 Using Gene Mapping to Understand Phenotypes 
 Knowledge about how specific genes influence mammalian development began in the 
early 1900s with experiments on the inheritance of coat colors in a variety of domestic animals 
(Hogan, Costantini, & Lacy, 1994). In 1903, the Boveri-Sutton chromosome theory was 
established, further clarifying Mendelian laws of inheritance by demonstrating chromosomes 
were central to genetic inheritance (Sturtevant, 1913). Shortly after, Thomas Hunt Morgan 
confirmed the chromosome theory through his observation of different traits within fruit flies, 
such as eye color and body color, making Morgan the first person to link trait inheritance to a 
specific chromosome (Miko, 2008). This led Alfred Sturtevant to determine the relative location 
of genes to one another on a chromosome and to generate the first genetic map of a chromosome 
(Sturtevant, 1913). Thus, genetic mapping is a powerful approach to identify chromosomal 
locations of genes influencing variation in phenotypic traits. Furthermore, it can facilitate a better 
understanding of the complex genetic organization of organisms. Approaches for mapping 
include methods such as linkage mapping and physical mapping. Although many biological 
mechanisms of simple, single gene phenotypes remain unknown, the advancement of mapping 
techniques and marker types continue to aid in connecting specific phenotypes to genotypes.  
 Preceding the knowledge of DNA sequences of genes, the location of genes could be 
mapped to specific chromosomes by tracking transmission in family pedigrees of specific 
phenotypes associated with different alleles of the same gene  (Chial, 2008). The first genetic 
maps used visual phenotypes as markers, with the only possible studies consisting of genes that 
correlated with these phenotypes (Brown, 2002). Sturtevant (1913) discovered the chance of 
recombination, or the exchange of DNA segments during meiosis, is related to the distance 
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between genes. Linkage analysis then estimates the distance between genetic loci and relies on 
the fact that genes near one another on a chromosome are likely to be inherited together. Two 
genes that are close together on a chromosome will be separated by recombination less 
frequently than genes that are farther apart. Therefore, recombination frequency is proportional 
to the relative distance between genes, leading to the capability of producing a linear map of 
genes along a chromosome. However, linkage mapping requires pedigree information in order to 
observe co-segregation or the tendency for linked genes to be inherited together. These early 
maps also lacked resolution, containing large uncharacterized genomic regions. These gaps 
consisted of genes without an associated phenotype, thus lacking the ability to be mapped.  
Because not all genes correlate with a visual phenotype, the discovery of DNA markers 
permitted great improvement in genetic mapping and genome characterization. DNA markers 
identify variation within an organism’s DNA sequence, producing a more comprehensive genetic 
map without the need for phenotypic variation. Restriction fragment length polymorphisms 
(RFLPs) were one of the first DNA markers implemented as part of the Human Genome Project. 
RFLPs are the result of a variation or polymorphism within a DNA sequence leading to a change 
in a restriction enzyme recognition site. DNA restriction enzymes recognize specific sequences 
and cleave the DNA molecules into fragments. A polymorphism within a restriction site results 
in sites that can no longer be cleaved by its restriction enzyme. Therefore, a sequence variation in 
restriction sites between homologous DNA sequences can be detected by their different fragment 
lengths after digestion with a specific restriction endonuclease (Botstein, White, Skolnick, & 
Davis, 1980). The RFLP assay, however, is time consuming and labor intensive, with few loci 
detected per assay (Powell et al., 1996).  
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Microsatellites soon became the marker of choice, being the first to take advantage of 
Polymerase Chain Reaction (PCR) (Zietkiewicz, Rafalski, & Labuda, 1994). Microsatellites are 
short segments of DNA that contain a di, tri or tetranucleotide repeat also known as simple 
sequence repeats (SSRs; Weber and May, 1988). They are abundant and fairly evenly distributed 
within an organism’s genome (Litt & Luty, 1989). Each locus is adjacent to a unique sequence 
and can be complimented by specific primers for use in the amplification of the microsatellite 
locus by PCR. Making use of PCR technology, microsatellites improved the speed of genetic 
mapping (Weber & May, 1989). However, use of these markers requires flanking sequence 
information. Also, microsatellite markers developed for one species exhirbit less homology 
across same or different taxa (Roa et al., 2000). 
Currently, single-nucleotide polymorphisms (SNPs) are the marker of choice when it 
comes to genetic mapping. SNPs differ by one or more nucleotides among individuals of the 
same species (Alberts et al., 2002). These polymorphisms have been characterized since the 
beginning of DNA sequencing, but their ability to be rapidly genotyped in large numbers came 
about with the advancement of high-throughput SNP technology platforms (Chee Seng, 
Katherine, & Kee Seng, 2001). SNPs are currently widely used on any size scale due to their 
abundance within genomes and their ability to identify polymorphisms missed by other markers 
(I. C. Gray, Campbell, & Spurr, 2000). Therefore, using SNPs as markers lead to an increase in 
mapping efficiency (Hoskins et al., 2001). 
 It was first shown by Risch and Merikangas (1996) that performing an association scan of 
one million variants in a genome within samples of unrelated individuals had the potential to be 
more effective than conducting linkage analysis with only a few hundred markers. They argued 
that the linkage analysis method had limited power in detecting genes of modest effect and an 
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association study approach utilizing candidate genes would give a greater outcome. The 
experimental design of genome wide association studies (GWAS) has led to new discoveries 
about genes and pathways involved in common diseases and traits. These studies are aimed at 
detecting variants at genomic loci that associate with complex traits within populations. This 
approach involves rapidly scanning markers across genomes of many individuals to find genetic 
variations, particularly SNPs, associated with the disease of interest (Norrgard, 2008). They are 
based upon the principle of linkage disequilibrium at the population level (Visscher, Brown, 
McCarthy, & Yang, 2012). Genome-wide association studies have resulted in detection of 
hundreds of common variants whose allele frequencies correlate with various illnesses, traits, 
and phenotypes continuing to provide the scientific community with an abundance of new 
biological information for clinical utilization (McClellan & King, 2010). 
 
1.2 Developmental Duplications Phenotypes 
 Developmental duplications (DD) is a congenital autosomal recessive condition recently 
characterized in cattle. Phenotypic presentations of affected calves consist of anatomic 
duplications derived from neural crest tissues. Specifically, phenotypes of DD consist of various 
forms of polymelia as well as neural tube defect malformations. Polymelia is also referred to as 
supernumerary, or extra limbs, and is often associated with other congenital defects such as 
polydactyly and the addition of often underdeveloped bones (Muirhead, Pack, & Radtke, 2014). 
There are many different forms of polymelia, each classified by the point of attachment to the 
body (L. Denholm, 2011). Notomelia consists of attachment of the additional limbs in the 
embryonic notochord region, cephalomelia is attachment to the head, thoracomelia is on the 
thorax below the dorsal midline, and dipygus, also known as pygomelia, is attachment to the 
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pelvic region. The extra limb can develop as a forelimb or hindlimb and have either a left or right 
side anatomy. It is not uncommon for an affected individual to have more than one 
supernumerary limb. In most cases however, the extra limb is shorter and consists of no muscle 
mass (L. Denholm, 2011). Polymelia poses a significant economic impact due to losses from 
dystocia and the high costs associated with amputation in affected calves that survive birth. 
Many calves with this condition appear to grow and breed normally despite removal or 
maintenance of the supernumerary limbs (L. Denholm, 2011).  
 Aside from polymelia, DD affected individuals present with congenital malformations 
that are associated with neural tube defects (NTDs). NTDs are the second most common group 
of birth defects among humans (Wallingford, Niswander, Shaw, & Finnell, 2013). NTDs are 
characterized by disruption of early embryonic events during central nervous system formation 
that result in failure of neural tube closure. There are a variety of malformations classified under 
the general description of NTDs, with a wide range of clinical severity. Among severe NTDs 
affecting brain development, cases of open lesions of the brain have been observed in DD 
affected individuals, often lethal at or before birth (Copp and Greene 2013). Lethality is a result 
of the failure of primary neurulation and is characterized by bending of the neural plate and 
closure of the neural tube in the dorsal midline (Gilbert, 2000). Closed spine lesions are less 
severe, sometimes even asymptomatic, often occurring in the low sacral and coccygeal region 
during secondary neurulation that generates the secondary neural tube (Murdoch et al., 2014). 
Among spinal cord malformations, cases of sacral spina bifida along with its severe form of 
myelomeningocele and associated spinal cord tethering, butterfly vertebrae and split cord 
malformation have been observed in DD affected individuals  (L. J. Denholm et al., 2016).  
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 Tumor-like cases include spinal embryonic teratoma, sacral and occipital myolipoma, 
dermoid cysts and dermoid sinus. Other NTD phenotypes with DD consist of twinning defects 
such as heteropagus rachipagus and conjoined twins, craniofacial dysmorphogenesis and 
micropthalmia as well as gastrochisis. Both genetic and non-genetic factors are known 
contributors in the development of NTDs with up to 70% being genetically attributed (Andrew J. 
Copp & Greene, 2013). However, the precise contribution of genetic factors such as function, 
number, or prevalence in affected individuals is still largely undiscovered for specific risk genes. 
The various NTD phenotypes associated with DD affected individuals will aid in further 
understanding the role genes have in NTDs in general.  
 
1.2.1 Mammalian Neurulation and Key Signaling Pathways  
 Neurulation results in formation of the neural tube, the precursor of the brain and spinal 
cord and ultimately forms the central nervous system (Andrew J. Copp, Greene, & Murdoch, 
2003). This is an intricate process that involves many diverse cellular functions and chemical 
pathways (Sadler, 2005). Due to its complexity, the neurulation process can be interrupted at 
several key developmental time points, resulting in neural tube defects. Neurulation is broken 
down into a two-stage progression within birds and mammals, known as primary and secondary 
neurulation.  It develops in a cranial to caudal, or head to toe, direction without any interaction 
between the two stages (A. J. Copp & Brook, 1989).  
 Primary neurulation involves the formation of the neural tube between the forebrain and 
caudal neuropore, or the opening that forms during folding of the neural tube (Morriss-Kay, 
Wood, & Chen, 2007). According to Schoenwolf and Smith (2000), primary neurulation occurs 
in four stages;  1) initiation by the formation of the neural plate, 2) shaping of the neural plate, 3) 
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bending and fusion of the neural folds and 4) neural groove closure (Figure 1.1). These stages 
occur simultaneously, each in their own anatomical region. Ectodermal thickening caused by the 
change in cuboidal to columnar epithelial cells results in the formation of the neural plate 
(Purves, Augustine, Fitzpatrick, & et al., 2001).  The neural plate is then shaped by narrowing 
and extending, otherwise known as convergent extension, as well as continued thickening (Zohn 
& Sarkar, 2008). The planar cell polarity (PCP) pathway, a non-canonical WNT signaling 
cascade, is required for the shaping stage (Massa et al., 2009). The bending of the neural plate 
requires formation of hinge points, neural folds, and neural plate folding and is regulated by the 
sonic hedgehog (Shh) signaling pathway as well as bone morphogenetic protein signaling 
(Andrew J. Copp, et al., 2003; Massa, et al., 2009). According to Gilbert (2000), two types of 
hinge points form during neural plate bending, the medial and dorsal lateral hinge points. The 
hinge regions are where the neural tube comes into contact with adjacent tissue. The movement 
of cells around the hinge points forms bilaminar folds, their inner layer containing the neural 
plate and an outer layer of epithelial ectoderm. These neural folds then ascend with the help of 
the medial hinge point, and pair with dorsal lateral hinge points. As a result of bending, the 
neural folds begin to align at the dorsal midline and with signaling from the PCP pathway, neural 
tube closure is initiated (Andrew J. Copp, et al., 2003; Sadler, 1978). Neural tube closure is 
initiated at several points along the rostrocaudal axis in mammals and birds (Yamaguchi & 
Miura, 2013). The folds adhere to one another and merge together, creating a tube like structure, 
hence the term neural tube. Surface epidermal ectoderm formerly bordering the neural plate then 
encases the newly formed neural tube (Oppenheim & Haverkamp, 1986). This primary 
neurulation stage results in the development of the brain and most of the spinal cord. 
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Figure 1.1 Primary Neurulation. (A) The 
neural plate is formed by the change in 
cuboidal to columnar epithelial cells. The 
neural plate is shaped by convergent extension 
movements while neuroepithelium continues to 
thicken requiring the PCP pathway. (B) The 
neural folds begin to ascend and pair with 
dorsal lateral hinge points.  (C) Neural folds 
converge at the dorsal midline. (D) Neural folds 
adhere to one another and create a tube like 
structure. Neuroepithelium, blue; dorsal neural 
tissue and neural crest, yellow; epidermis, light 
blue; notochord, red. (Image adapted from 
(Wallingford & Harland, 2002). 
 
 
 Occurring at the future base of the spine, the transition between primary and secondary 
neurulation begins (Andrew J. Copp & Greene, 2013). According to Copp (2003), secondary 
neurulation is formed within the tail bud, or lowest spinal region, without the need for neural 
folding. The tail bud is composed of a self-renewing stem cell population that is left after the 
primitive streak diminished. The primitive streak consists of a band of cells that form during 
early gastrulation, also known as a precursor for neural tube development (Gilbert, 2000). These 
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cells proliferate rapidly and contribute to the longitudinal development of the body axis, 
becoming the main source for all non-epidermal tissues, including the neural tube and vertebrae. 
The guided movement of mesenchymal cells from the tail bud create the secondary neural tube, 
forming a continuous lumen within the primary neural tube (Zohn & Sarkar, 2008). This process 
results in the formation of the lowest section of the spinal cord.  
 The bending and shaping of the neural plate that is necessary to complete the neural tube 
is thought to be dependent upon cranial neural crest cell migration (Andrew J. Copp, et al., 
2003). According to Hogan et al. (1994), the neural crest is a population of cells originating in 
the dorsal part of the neural tube. Crest cells migrate away from the neural tube to ventral and 
dorsolateral locations to become a wide variety of cell types based on their axial location. In the 
midbrain and hindbrain, crest cells detach from the neural folds and begin to migrate before the 
initiation of neural tube closure (Yamaguchi & Miura, 2013). However, in the spinal, or lower 
region, neural crest cell migration begins hours after the completion of neural tube closure 
(Andrew J. Copp, 2005).  
 Programmed cell death, also known as apoptosis, plays an important role in animal 
development such as removing cells between digits as well as being involved in the hollowing of 
structures creating cavities (Jacobson, Weil, & Raff, 1997). A study conducted by Schluter 
(1973) observing mouse embryos under an electron microscope for zones of cell death, first 
provided evidence that cell death within the neuroepithelium during neurulation is programmed. 
In 1993, the role of caspase enzymes in apoptosis was discovered, cleaving one another and key 
intracellular proteins in order to execute cells in a controlled manner (McIlwain, Berger, & Mak, 
2013). Weil et al. (1997) suppressed apoptosis in developing chick embryos by inhibiting 
caspases, resulting in the failure of neural tube closure, thus ultimately proving the requirement 
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of apoptosis during mammalian neurulation.  Massa (2009) also investigated the role of 
apoptosis in neurulation and was able to show that it occurs mainly during the bending and 
fusion of the neural folds, post fusion remodeling of the neural tube, and migration of the neural 
crest cells away from the neural tube. This study also suggests that excess apoptosis could cause 
NTD development by causing a lack of cells needed in order to successfully complete neural 
tube closure. In mice, several KO strains with NTD development contain alterations in the 
normal amount of apoptotic cells. Most of these strains show an increase in cell death as well as 
having a few genetically determined mouse NTDs in connection with reduced apoptosis, further 
emphasizing the correlation between neurulation and apoptosis (Muriel J. Harris & Juriloff, 
2007). Copp’s (2003) neurulation review states that the neuroepithelium is also proliferative 
during neurulation, with cells beginning to leave the cell cycle and differentiate only after neural 
tube closure is complete at each point along the body axis. Excessive cell proliferation, however, 
has been identified in individuals with neural tube defects; leading to the conclusion that 
successful neurulation requires a balance between proliferation and differentiation of cells.  
 
1.3 NHLRC2, the gene for developmental duplications 
 Bovine developmental duplications is caused by a mutation in the NHL repeat containing 
(NHLRC2) gene. NHLRC2 is a protein coding gene with known and predicted orthologs in 181 
organisms (Pruitt et al., 2014). In the mouse, NHLRC2 is highly expressed within the nervous 
system (Smith CM et al., 2014). There is presently no known function of the NHLRC2 protein, 
but it has been shown to be linked to late-onset Alzheimer Disease in humans (Grupe et al., 
2006).  Currently, no mutations in the NHLRC2 gene or associated phenotypes have been 
reported in any species other than cattle. 
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1.3.1 NHLRC2 Gene Organization 
 NHLRC2 is located on bovine chromosome 26 and has 12 exons, spanning approximately 
55.59 kb (NCBI Reference Sequence: NM_001083723.2). Bovine NHLRC2 has one transcript 
and contains 726 amino acids (Herrero et al., 2016). Mouse NHLRC2 is located on chromosome 
19, with 11 exons, spanning 55.24 kb (NCBI Reference Sequence: NM_025811.3). Mouse 
NHLRC2 also has one transcript and contains 725 amino acids (Pruitt, et al., 2014). 
 
1.3.2 Related Gene Family Members 
 The NHLRC2 gene is one of four NHL repeat containing proteins involved in protein-
protein interactions and is named after the NCL-1, HTA and Lin-41 genes first discovered and 
named for the 2-6 repeats of an approximate 44-residue protein domain (Slack & Ruvkun, 1998). 
NHLRC2 has a thioredoxin and 6-blade b-propeller TolB-like domain. Thioredoxins are major 
cellular protein disulfide reductases serving as electron donors for enzymes (Arnér & Holmgren, 
2000). They also protect proteins from inactivation, help cells deal with stress, and regulate 
programmed cell death by removing nitric oxide elements, or denitrosylation  (Collet & 
Messens, 2010).  
 
1.3.2.1 NHLRC1 
Although NHLRC2 is not well characterized, NHLRC1 has been shown to play a role in 
disease (Chan et al., 2003). NHLRC1 is one of the four NHL repeat-containing protein family 
along with NHLRC2 (Pruitt, et al., 2014). NHLRC1 is a single exon gene, having two transcripts 
(Chan, et al., 2003). NHLRC1 is referred to as the NHL Repeat Containing E3 Ubiquitin Protein 
Ligase 1 (Singh & Ganesh, 2009). NHLRC1 is predicted to produce a 395 amino acid protein 
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known as malin. Chan (2003) discovered NHLRC1 as a causative gene, along with the previously 
discovered EPM2A gene, in the onset of the autosomal recessive Lafora disease (LD), a 
progressive and fatal neurodegenerative disorder also known as progressive myoclonic epilepsy 
type 2. Symptoms of LD include cognitive defects, myoclonic epilepsy, ataxia and dementia 
(Singh & Ganesh, 2009). These mutations result in the accumulation of the phosphatase laforin, 
that is otherwise normally polyubiquitinated by NHLRC1 (Brackmann, Kiefer, Agaimy, Gencik, 
& Trollmann, 2011). Ubiquitination directs proteins for degradation through the proteosome, 
alters protein location, and affects protein activity and protein-protein interactions (Glickman & 
Ciechanover, 2002).   
NHLRC1 mutations impair the encoded protein malin from normally degrading laforin 
(Brackmann, et al., 2011). This results in intracellular deposits of insoluble glycogen within 
neurons, thus making the degradation of laforin a key aspect in regulating cell death. A more 
recent study investigated the possible role the NHLRC1 protein may have in the p53 mediated 
cell death pathway (Upadhyay, Gupta, Bhadauriya, & Ganesh, 2015). It was observed that loss 
of lafora or malin resulted in increased levels and activity of p53, a cell cycle regulator. This 
outcome is primarily due to the associated increased level of Hipk2, a proapoptotic activator of 
p53, suggesting overall that the activation of Hipk2-p53 cell death pathway may be the cause of 
cell death, or neurodegeneration as seen in Lafora disease. 
 
1.3.2.2 Slimb  
 A genetic basis of supernumerary limbs is demonstrated in the slmb (supernumerary 
limbs) gene within the fruit fly Drosophila melanogaster. Slmb is one of three F-Box/WD40 
repeat proteins with the Drosophila genome. WD repeat proteins resemble that of NHL repeats; 
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they are both known to be involved in protein-protein interactions, contain multiple repeat units 
and are of similar length (Neer, Schmidt, Nambudripad, & Smith, 1994). F-Box/WD40 proteins 
are subunits of a multi-protein complex and are components of E3 ubiquitin ligases, recruiting 
substrates such as cell cycle regulators in yeast and other substrates within mammals to the 
ubiquitin-dependent proteolytic system (L. Denholm, 2011; Kawakami et al., 2000). The 
ubiquitin-proteasome pathway consists of connecting ubiquitin polypeptides to proteins targeting 
them for degradation, making it an important pathway for protein regulation in eukaryotes 
(Lecker, Goldberg, & Mitch, 2006). The Interactive Fly database (2000) classified slmb as an 
important regulator of the Wingless (Wg), Hedgehog (Hh), and dorsal developmental pathways. 
Jiang and Struhl’s (1998) review on slmb states that the gene is normally negatively regulated by 
both the Hh and Wg signal transduction pathways. Hh signal transduction leads to the increased 
stability of the patterning formation transcription factor cubitus interruptus (ci) and Wg signal 
transduction leads to increased stability of the cell adhesion armadillo (arm) gene (Fly, 1996; 
Peifer, Orsulic, Sweeton, & Wieschaus, 1993). Loss of function mutations within the slmb gene 
results in mutated cell accumulation of both ci and arm as well as abnormal expression of both 
the Hh and Wg responsive genes.  
Jiang and Struhl (1998) classified the three slmb alleles; slmb¹ was observed to behave 
hypomorphically, causing partial loss in gene function, while slmb² and slmbP1493 elimate most to 
all of slmb’s function, their mutant cells showing phenotypes attributed to abnormal Wg and Hh 
signal transduction. Wojcik (2000) later found that slmb is required in Drosophila neuroblasts to 
restrict centromere duplication during the cell cycle, emphasizing its role during central nervous 
system development. Theodosiou (1998) found slmb also regulates Wg and decapentapliegic, a 
key developmental morphogen, in both the anterior/posterior and dorsal/ventral axes. These 
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studies demonstrate the slmb gene being a key regulator in body pattern development within 
Drosophila. Although the function of NHLRC2 is not well characterized, it has phenotypic 
characteristics like that of slmb suggesting these two genes have similar functions, being a key 
factor during development. 
 
1.4 Use of a Mouse Model 
 Animal models are a valuable resource for studying orthologous diseases between 
species. Basic cell processes in most mammals are very similar due to their related anatomy. 
Thus, biological research using animal models facilitates our understanding of the development 
and function of organisms. Furthermore, the use of animals in research has significantly helped 
accelerate scientific progress and is a key contributor to the development of effective drugs, 
therapies and cures used today (Hau, 2008).  
 Rodents have been used in research for nearly a century and make effective models in 
research due to their well understood anatomy, physiology, and genetics (Hau, 2008). According 
to the Foundation for Biomedical Research, 95% of all laboratory animals are mice and rats 
(Melina, 2010). The mouse model in particular is a powerful research tool because of their cost 
effectiveness, in large part due to their size and rapid regeneration time. Mice have a 19-21 day 
gestation period and produce a relatively large litter size, with reproduction possible as often as 
every three weeks (Hogan, et al., 1994). They can also be highly inbred to yield identical 
individuals, allowing for uniformity within a research colony. 
 The mouse is also an excellent organism for genome manipulation. This makes it a well-
known organism for generating disease models through manipulation of known causative genes 
(Spencer, 2002). The Jackson Laboratory, a top laboratory mouse distributor with the most 
15 
 
published mouse models in the world, currently maintains over 7,000 genetically defined strains 
of mice (Shultz, 2016). Models currently available for genetic research include mice prone to 
specific cancers, diabetes, obesity, blindness, Huntington’s disease, anxiety, behavior, addiction, 
as well as many others.  
 Genetic mouse models have also been recognized to be an important tool when studying 
neural tube closure in mammals (J. Gray & Ross, 2011). NTD mouse models allow for the 
identification of neurulation genes by observing embryonic development. These mouse models 
provide an accommodating system for discovering the development, pathological and molecular 
mechanisms that bring about NTDs (Zohn & Sarkar, 2008). The current number of mouse 
mutants containing NTDs is more than 240, consisting of 205 with specific causative genes, 30 
unidentified genes, and 9 multifactorial strains (Muriel J Harris & Juriloff, 2010).  
 
1.4.1 Mouse Developmental Timeline 
 Mice are an effective research tool when investigating development due to their 
gestational period lasting a mere 19-21 days. Embryonic development begins with fertilization of 
the egg by the sperm, cleavage and blastulation occurs during embryonic days (E) 0-5; 
implantation, gastrulation and early organogenesis during E5-10.0, organogenesis occurs 
between E10-14.0, and the last period of fetal growth and development occurs between E14-19.0 
(Hogan, et al., 1994). The first period that occurs encompasses from fertilization to implantation 
and is known as the preimplantation period (Wang & Dey, 2006). The success of preimplantation 
is dependent upon the degradation of maternal debris, activation of the embryo’s genome, cell 
cycle progression ensuring appropriate initial cell lineages, as well as the formation of a 
blastocyst with subsequent implantation on the uterine wall (Li, Zheng, & Dean, 2010). 
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Beginning on E0.5, the embryo is composed of only one cell. By E1.5, the embryo is at the 2 cell 
stage and has initiated expression of its own genome (Hogan, et al., 1994). After the four cell 
stage on E2.0, the embryo continues to go through several mitotic cell divisions, forming a ball 
of cells that undergo compaction. These compacted cells are known as the morula and develop 
apical and basal membranes (top and bottom) (Marikawa & Alarcón, 2009). Upon compaction, a 
fluid-filled blastocoel cavity forms on E3.5 and becomes a blastocyst (Fong et al., 1998). The 
mature blastocyst is composed of three cell types: the outer epithelial trophectoderm, the 
primitive endoderm, and the pluripotent inner cell mass (ICM) (Wang & Dey, 2006). 
 Localization of the embryo ICM defines the polar and mural trophectoderm with the 
mural trophectoderm located opposite the ICM (Sutherland, 2003). On E4.5, implantation into 
the uterine wall of the fully formed blastocyst is initiated by the mural trophectoderm’s 
connection with the luminal epithelium of the uterus (Li, et al., 2010). During implantation, there 
is an increase in endometrial vascular permeability at the site of blastocyst attachment (Zhang et 
al., 2013). Following the completion of implantation, there is a dramatic increase in the embryo’s 
growth rate, specifically in the pluripotent cells of the epiblast or primitive ectoderm from which 
the fetus develops (Hogan, et al., 1994). Shortly after implantation, the anterior-posterior axis of 
the embryo is firmly established (E5.5) (Takaoka & Hamada, 2012). 
 Blastocyst attachment induces the formation of the uterine crypt and also stimulates 
formation of decidual tissue, a spongy mass of cells originating from the uterine stroma known 
as the decidual reaction (Zhang, et al., 2013). These cell masses around a single embryo are 
referred to as the deciduum, translating to ‘that thing that falls off’ (Hogan, et al., 1994). 
According to Palis (2006), gastrulation begins at E6.5 as mesodermal cells pass through the 
primitive streak to occupy a position between the primitive ectoderm and visceral endoderm 
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germ layers. At E7.0, mesoderm cells migrate to line the exocoelomic cavity and enter the 
embryo proper, eventually differentiating into the mature embryo. E7-7.5 marks the initiation of 
yolk sac formation. The yolk sac is a bilayer structure of mesoderm and endoderm derived cell 
layers that the survival of the embryo becomes dependent upon. In addition to the yolk sac, the 
development of the neural plate begins at E7-7.5. According to Gray and Ross (2011), neural 
tube closure begins at E8.5 at the hindbrain/cervical boundary prior to embryo turning. The 
conclusion of cranial neural fold and caudal neuropore closure occurs on E9.5, with cranial 
neurulation completed by E10.0 (Andrew J. Copp & Greene, 2013; J. Gray & Ross, 2011).  
 Hogan (1994) states that forelimbs begin appearing at E9.0 with hind limbs becoming 
detectable at E10. Bone and cartilage elements for limbs are derived from the lateral mesoderm 
of the initial outgrowth and the limb musculature initiates from myotome cells migrating from 
the somite into the limb bud at a later stage. As limb bud growth continues, the surface ectoderm 
overlying the distal tip thickens into the apical ectodermal ridge (AER), essential for maintaining 
proliferation and patterning of the underlying progress zone (PZ). Anterior/posterior patterning 
of the limbs requires the zone of polarizing activity (ZPA). Members of the Hox gene family (A 
and D) that control an embryo’s body plan along the head to tail axis, are expressed in a region 
specific manner within the limb. Cartilage formation in the developing embryo is complete on 
E12.5 and bone formation complete by E15.0 (Hogan, et al., 1994). Fetal growth development is 
the final stage during gestation, occurring from E14.0 until birth.  
 
1.4.2 Bovine developmental timeline  
 Embryonic development within the cattle is similar to that of the mouse, but occurs over 
a much longer gestation period of approximately 285 days, although this can vary significantly 
depending on breed as well as environmental factors (Andersen & Plum, 1965). According to 
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Waters (2013) during bovine embryogenesis the embryo divides to 2 cells on E1.0, 4 cells by 
E1.5 and consists of 8 cells by the end of E3.0. The morula forms on E5.0 at the 16-32 cell stage 
and travels down the oviduct entering the uterus between E5.0 and E6.0. The morula is then 
compacted during E6.0 initiating the formation of the blastocoel cavity, with blastocyst 
development beginning on E7.0 (Lindner & Wright, 1983). On E8.0 there is continued expansion 
of the blastocyst and the ICM is formed, with the blastocyst hatching from the zona pellucida on 
E9.0 (Chang, 1952). Between E15 and E17 there is maternal recognition of pregnancy and at 
E18 portions of the developing cells become the placenta along with formation of the primitive 
groove and emergence of the notochord (Greenstein & Foley, 1957).  Implantation occurs by 
E19 with adhesion being complete by E22, (King, Atkinson, & Robertson, 1980). According to 
Maddox (2003) primitive streak and neural groove formation occurs on E21. By E23 the bovine 
embryo has complete formation of the hypoblast and epiblast, establishment of the amniotic 
cavity, formation of the primitive streak (with precursor cells previously formed at E14), 
endoderm and mesoderm formation, and neurulation and differentiation of mesodermal cells. 
Limb development begins on E25 as well as organogenesis (Waters, 2013). Fourie (1990) 
recognizes the critical stage of limb development within the bovine fetus is from Day 24 to 40 of 
gestation. Like that of the mouse, the majority of bovine fetal growth occurs during the last 
trimester of gestation until birth where 75% of its total fetal weight is gained (Waters, 2013).  
 
1.5 Gene-editing 
 Genome editing is the process of editing an organism’s DNA by removal, addition or 
alteration of nucleotides to its genome (Kim 2015). Current genome editing methods have the 
capability to alter virtually any gene in a diverse range of cell types and organisms (Gaj, 
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Gersbach, & Barbas, 2013). The first report of direct introduction of new genetic material into an 
embryo came from Jaenisch and Mintz (1974) with the discovery that viral DNA sequences 
could be detected in somatic tissues after SV40 DNA, a virus with the potential to cause tumor 
growth, was injected into the blastocoele cavity of mouse blastocysts (Jaenisch & Mintz, 1974).  
 A whole new era of genome editing began after Gordon’s (1980) discovery that 
exogenous DNA can be efficiently incorporated into a mammal’s chromosomes when injected 
into the nucleus. This incorporation of new DNA occurs through homologous recombination in 
which DNA molecules recombine with each other through their shared homologous regions. 
Bradley and Evans et al. (1984) successfully completed blastocysts injection techniques to 
provide evidence of embryonic stem cells (ES) contribution to functional germ cells. They then 
went on to discover ES cells could be used to introduce genetic material into the germline. Their 
experiment consisted of infecting ES cells with a recombinant retrovirus before injection into 
blastocysts. The study was successful after confirmation of the retroviral DNA in the founders 
and F1 offspring (Evans, Bradley, Kuehn, & Robertson, 1985). Morgan and Capecchi (1986) 
successfully used this technique to correct a defective gene by injecting copies of the same gene 
with a different mutation into the mammalian nucleus. After first establishing cell lines with a 
mutant gene integrated into the host’s genome, Morgan and Capecchi injected DNA containing a 
different mutation within the gene, resulting in the restoration of the gene through homologous 
recombination.  
 The discovery that targeted DNA double stranded breaks (DSBs) could be used to 
stimulate endogenous cellular repair machinery set the foundation for gene-editing (Takata et al., 
1998). DSBs occur from events such as ionizing radiation, spontaneous DNA replication, and by 
programmed endonucleases that cleave the phosphodiester bond (Haber, 2000). Mao (2008) 
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states that both strands of the double helix are broken during a DSB and can ultimately lead to 
genome rearrangement. Specifically, if a DSB is left unrepaired, or repairs itself in the wrong 
way, it could result in the loss of genetic information or genetic rearrangements. These events 
can lead to a loss of gene function affecting key pathways. For example, if enough damage is 
done by an unrepaired DSB, an apoptotic gene pathway could be activated at the wrong time 
during development, resulting in excess cell death (Mao, et al., 2008). Within eukaryotes, there 
are two known general DSB repair pathways, homologous recombination (HR) and non-
homologous end joining (NHEJ) (Takata, et al., 1998). While both pathways play important roles 
in the DSB repair process, HR results in more accurate repairs while NHEJ is error prone (Gaj, et 
al., 2013; Maeder & Gersbach, 2016). The HR repair mechanism is cell cycle dependent, acting 
in coordination with the S and G2 cell cycle phases, after DNA replication but before cell 
division occurs and involves the use of nearby sister chromatids (Brandsma & Gent, 2012; 
Sonoda, Hochegger, Saberi, Taniguchi, & Takeda, 2006). HR uses regions of homology between 
exposed ends of the DSB and a donor DNA molecule as a template during repair (San Filippo, 
Sung, & Klein, 2008).  In contrast, the NHEJ repair pathway is independent of homology and 
acts in a non-template manner, rejoining what is left of the two DNA ends  producing junctions 
that vary in sequence (Lieber, 2008; Mao, et al., 2008).  
 Recent advances in genome manipulation have been made through engineered nucleases 
with programmable, site specific DNA-binding domains (Perez-Pinera, Ousterout, & Gersbach, 
2012). There are currently several types of engineered nucleases that induce site-specific double 
stranded breaks; zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases 
(TALENs) The first engineered nuclease technology, zinc finger, was first used in 2002 on 
Drosophila and mammalian cells (Ma & Liu, 2015; Pavletich & Pabo, 1991). ZFNs are highly 
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specific, with each domain engineered to recognize a nucleotide triplet within the genome. They 
are manufactured from zinc fingers, or proteins that recognize and bind to specific triplet 
sequences, their folding structure determined by a zinc ion. ZFNs are usually composed of 4-6 
zinc finger domains fused to the non-specific nuclease domain of the FokI restriction 
endonuclease (Wright, Li, Yang, & Spalding, 2014) The FokI nuclease functions as a dimer, 
requiring two ZFNs to bind on opposite strands of the DNA in order to induce a DSB (Maeder & 
Gersbach, 2016). ZFN-induced DSBs are used to modify the genome by insertion or deletion 
through NHEJ (Ma & Liu, 2015). 
The genome targeting capabilities of transcription activator-like (TAL) effectors was 
discovered in 2009, stimulating the engineering of a new gene editing tool known as TALENs 
(Moscou & Bogdanove, 2009). TALENs soon became preferred over ZFNs due to the specificity 
of their TALEs consisting of 33-35 amino acid repeat domains, each domain recognizing a single 
base pair (Ma & Liu, 2015). The specificity of base recognition is determined by the 
hypervariable amino acids 12 and 13 that interact with the targeted DNA bases, also known as 
repeat-variable di-residues (RVDs) (Boch et al., 2009). There are four major RVDs; HD, NI, NG 
and NN that most commonly bind to cytosine, adenine, thymine, and guanine respectively 
(Wright, et al., 2014). TALE repeats are then linked together to recognize continuous DNA 
sequences. Like ZFN, these TALEs are fused with the sequence independent FokI endonuclease 
at the c-terminal end of the protein inducing the DSB. Their targeting range, simple DNA code 
and ease of engineering has led to their popularity as artificial transcription factors and 
nucleases; as of 2014, TALENs have been successfully used in over 25 species including  plants, 
zebra fish, frogs, rats, pigs, mice, and in human somatic and pluripotent stem cells. 
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The latest gene-editing technology, clustered regularly-interspaced short palindromic 
repeat (CRISPR)/CRISPR-associated (Cas) systems, (CRISPR/Cas9), has the ability to target 
many genes at once, providing an advantage for studying complex diseases caused by many 
genes acting together. There are currently three types of CRISPR systems (I, II, III) with type II 
being the most common due to its single protein requirement, Cas9, for target cleavage (Pruett-
Miller, 2015).  Cas9 is a RNA-guided nuclease that is able to bind to target DNA and induce a 
DSB (Garneau et al., 2010). According to Ran (2013), CRIPSR/Cas is an adaptive immune 
system consisting of Cas genes, noncoding RNAs and a distinct array of repetitive elements. 
These repeats contain a variable 20 bp sequence from exogenous DNA targets or protospacers, 
making up the CRISPR RNA (crRNA) array. Within the target DNA, each protospacer is 
associated to its adjacent motif (PAM). Each crRNA contains a 20 nucleotide sequence that 
directs Cas9 to the targeted DNA where it induces a DSB.  
Through the use of gene editing technology, model organisms carrying disease mutations 
are created in order to further study gene function and pathogenesis, as well as having the 
possibility to correct causative mutations in gene therapy.  Specifically, ZFNs  have been used to 
correct the mutations that cause the X-linked severe combined immune deficiency (SCID) 
(Urnov et al., 2005). Modeling gene rearrangements through TALEN technology has led to the 
discovery of a drug resistant mechanism in prostate cancer (Wright, Li et al. 2014). The 
CRISPR/Cas9 system has been successfully used to correct disease-related genes in the mouse 
and in intestinal stem cells of a cystic fibrosis patient (Wu et al., 2013). Overall, these tools are 
revolutionizing biological research and medicine with the improving ability to understand and 
treat disease. 
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Chapter 2: Characterization of a Mouse Model for Bovine Developmental Duplications 
2.1 Introduction 
 Developmental Duplications is an autosomal recessive genetic condition recently 
discovered in Angus cattle. It is a congenital abnormality where duplication of the neural crest 
derived tissues occurs during embryonic development. Congenital limb abnormalities are 
relatively common in domestic animals and humans (Fourie, 1990). However, while sporadic 
cases in cattle have been reported in both Bos taurus and Bos indicus breeds around the world, 
Denholm (2011) reported that polymelia seemed to be rising above the sporadic level in 
Australia among registered Angus cattle. At least fifteen cases were reported in newborn Angus 
calves within two years, with many other cases being reported in the US. This observation 
suggested the possibility of an emerging heritable defect. The majority of bovine cases are noted 
as notomelic, with the extra forelimbs being attached along the dorsal midline. A common 
phenotypic presentation of the condition includes calves born with various forms of polymelia 
(notomelia, cephalomelia, pygomelia), having frequent duplication of the front limbs originating 
from the neck or shoulder region. Calves homozygous for this mutation also show congenital 
malformations associated with neural tube defects. Malformations include myelomeningocele, 
split cord malformation, spinal embryonic teratoma, sacral and occipital myolipoma, 
encephalocele, and craniofacial dysmorphogenesis. 
 Genome wide association studies identified a single locus associated with the DD 
phenotype. Further investigation identified a nonsynonymous valine to alanine substitution in 
exon 5 of the NHLRC2 gene, a locus where valine is invariable in 53 known species of diverse 
taxa (Figure 2). Penetrance of DD phenotypes of affected individuals is less than 50% (L. J. 
Denholm, et al., 2016). Due to its incomplete penetrance and undetected embryonic loss, 
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population allele frequency was ~3% in the United States and ~7% in Australia by the time DD 
was recognized as a syndrome. The purpose of this study was to confirm the role of NHLRC2 in 
DD and to further characterize the role NHLRC2 in mammalian development through use of a 
mouse model.  
2.2 Materials and Methods 
TALEN Generated Mice 
 NHLRC2 gene-edited mice were produced in the Friend Virus B (FVB) mouse strain 
using TALENs (Cyagen Biosciences, Inc.). TALs and TALEN vectors were assembled by 
Cyagen Biosciences using the Golden Gate method (Cermak, et al., 2011). TALEN mRNA was 
generated by in vitro transcription and injected into fertilized eggs for gene-editing.  FVB mice 
are ideal for transgenic or knockout model development due to their prominent pronuclei in 
fertilized eggs along with their large litter size (The Jackson Laboratory). 
 Upon delivery from Cyagen Biosciences, mice were subjected to a quarantine protocol in 
the Division of Animal Resources Rodent Quarantine Facility. The quarantine protocol included 
disease testing of mice along with sentinel animal exposure and testing. Imported mice were 
checked for parasites and had blood drawn for initial serology testing. After 7 weeks, sentinels 
were euthanized for serology and parasitology testing. No agents of concern were identified and 
gene-edited mice were released from quarantine after nine weeks. Mice were kept in a 12-hour 
light/12-hour dark regimen with Standard Mouse Chow and water available at all times. Mice 
were initially housed separately. Litters born at the University of Illinois at Urbana-Champaign 
Rodent Facility were then housed together based on gender and genotype. 
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Animal Husbandry 
 A total of 15 founder mice were received. Founder mice were heterozygous for one of 
three NHLRC2 mutations induced by TALEN-editing. The heterozygous founder mice within 
each line were initially mated to wild type (WT) FVB mice to increase the size of the breeding 
population.  The resulting heterozygous offspring were then intermated to phenotypically 
characterize homozygous progeny. Mice were assumed to be sexually mature and optimal for 
breeding at six weeks of age (Lambert, 2007). Breeding was performed by placing one male with 
two to four females per cage for a one week period. Following the mating period, pregnant 
females were caged separately to allow for examination of the genotype ratio in each litter for 
each female. Additionally, individual housing of females was used to prevent excess cannibalism 
of dead pups. 
 Evidence of copulation was used as a method to harvest embryos of known gestational 
age. Before 10 A.M. on the morning following the initial exposure of females to a male, each 
female was examined for the presence of a vaginal plug (Silver & Barsh, 1995). Once a plug was 
detected, the female was removed from the cage and assumed to be pregnant. At a predetermined 
gestational age, females were euthanized and reproductive tracts were harvested as described 
below (see Dissection). 
 
PCR Genotyping   
 Oligonucleotide primers for genotyping were designed using Primer Designer v2.0 
(Scientific and Educational Software). Primers were designed to flank the targeted mutation site 
in exon 5 of mouse NHLRC2.  PCR amplification of the wild-type allele using the primers 
NHLDNAF 5’-AGCCAGCCTTCTATGACACT-3’ and NHLDNAR 5’-
26 
 
TCCCTTGAATACCGACACCA-3’ was predicted to produce a 167 bp amplicon. The reverse 
primer was fluorescently labeled with 6-FAM for fragment detection using an automated DNA 
sequencing instrument.  
Ear notching was used for individual mouse identification and simultaneous collection of 
tissue samples for DNA isolation. Genomic DNA was isolated using the Quick-gDNA™ 
MiniPrep kit according to the manufacturer’s recommendations (Zymo Research, Irvine, CA). 
Following extraction, genomic DNA was quantified by spectrophotometry using a NanoDrop 
instrument (Thermo Fisher Scientific, Inc.). 
 PCR amplification was performed in 10 μL reactions with each reaction composed of 1X 
Qiagen PCR buffer, 0.1 µM each primer, 200 µM each dNTP, and 0.025 U/μL Qiagen 
HotStarTaq DNA polymerase. Thermal cycling parameters include 5 minutes of initial activation 
at  95°C followed by 30 cycles of 30s at 94°C, 30s at 56°C and 30s at 72°C; this was followed by 
15 minutes at 72°C and 5 min at 10°C. To verify PCR quality, 5 μL of each reaction were mixed 
with 2 μL of 6X loading dye (15% Ficoll, 0.01% bromophenol blue) and subjected to 
electrophoresis in a 2% 0.5X TBE agarose gel containing 100 ng/mL ethidium bromide.  
Following electrophoresis DNA fragments were visualized under UV illumination.  
 Three μL of each PCR product was diluted with 80 μL of Optima water. Subsequently, 3 
μL of diluted PCR product were then dried in a vacuum evaporator. Dried samples were sent to 
W.M. Keck Center for Comparative and Functional Genomics at the University of Illinois for 
fragment analysis. The GeneScan™ 600 LIZ® size standard (Thermo Fisher) was used for 
assignment of fragment sizes. Genotypes were analyzed using GeneMarker™ V1.91 software 
(Softgenetics, State College, PA, USA). 
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Sequencing 
 Forward and reverse primers for cDNA amplification were designed using Primer 
Designer v2.0 (Scientific and Educational Software) beginning at exon 3 and ending at exon 6, 
flanking known deletions in exon 5. Product size of cDNA amplification was 438 bp.  
 Total RNA was extracted from whole brains of three heterozygous mice for each of the 
three mutations. Extraction was performed using TRIzol® reagent (Invitrogen™, Life 
Technologies Corporation) according to the manufacturer’s recommendations. Total RNA was 
quantified by spectrophotometry using a Nanodrop instrument (Thermo Fisher Scientific, Inc.). 
Quality of the RNA was assessed by electrophoresis in a 1.2% formaldehyde-1X MOPS agarose 
gel. Formaldehyde gel loading buffer was added to samples before loading. Prior to cDNA 
synthesis, 10 μg of total RNA was repurified using the RNeasy Mini Kit as described by the 
manufacturer (Qiagen).  
 Complementary DNA (cDNA) was synthesized in a 20 μL reaction by first combining 2 
μg RNA, 0.5 μM random decamers, and 0.5 mM dNTPs in a total volume of 13 μL followed by 
incubation at 65°C for 5 minutes and then snap cooled on ice for at least one minute. After 
cooling, reagents were added for a final concentration of 1X First strand cDNA synthesis buffer, 
5 μM DTT, 2 Units/μL RNaseOUT Recombinant RNase Inhibitor, and 10 Units/μL Superscript 
III reverse transcriptase. The resulting mixture was incubated at 25°C for 5 minutes for annealing 
random decamers, and then at 50°C for one hour. Reactions were inactivated by incubation at 
70°C for 15 minutes. Optima™ water (Fisher Scientific) was added to dilute the total volume to 
approximately 100 μL. PCR amplification was performed in 20 μL reactions with each reaction 
composed of 1X Qiagen PCR buffer, 0.5 μM each primer, 200 μM each dNTP, and 0.025 U/μL 
Qiagen HotStarTaq DNA polymerase. Thermal cycling parameters include 5 minutes of initial 
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activation at 95°C followed by 30 cycles of 30s at 94°C, 30s at 54°C and 30s at 72°C; this was 
followed by 15 minutes at 72°C and 5 minutes at 10°C. To verify product quality, amplicons 
were separated via electrophoresis on a 2% 0.5x TBE agarose gel containing 100 ng/μL ethidium 
bromide. A 2-log DNA ladder was used as a size reference (New England BioLabs). 
Cloning of PCR amplicons was performed using the NEB PCR Cloning Kit according to 
the manufacturer’s protocol. A 10 μL ligation reaction was prepared by first combining 1 μL of 
linearized pMiniT™ Vector with 1-2 μL of PCR product and adding Optima™ water up to 5 μL 
total volume. Then, cloning master mix was added to a final concentration of 1X and the ligation 
mixture was incubated at room temperature (25°C) for 5 minutes and then on ice for 2 minutes. 
Reactions were then transformed immediately into NEB 10-beat competent E. coli. Competent 
cells were first thawed on ice for 10 minutes before transformation. Two μL of each ligation 
reaction were added to cells for a 25:1 ratio and mixed by flicking of the tube five times. The 
mixture was incubated on ice for 30 minutes, heat shocked at 42°C for 30 seconds and then put 
back on ice for 5 minutes. SOC media was added for a total volume of approximately 1 mL. 
Cultures were placed at 37°C for 60 minute with agitation at 250 rpm for cell recovery. Cells 
were then mixed thoroughly by inversion and 50 μL of the cultures were spread onto 37°C pre-
warmed agar plates containing 100 μg/ml ampicillin. Plates were inverted and incubated at 37°C 
overnight. 
 Eight colonies from each plate were picked using sterile toothpicks and separately grown 
in 3mL of 2X Luria-Berani (LB) medium in snap cap tubes. Cultures were incubated with 
shaking overnight (18 hours) at 37°C. Plasmid DNA was purified using the the QIAprep Spin 
Miniprep Kit (Qiagen) according to the manufacturer’s recommendations. Plasmids were 
digested with Eco RI (New England Biolabs) to confirm presence of inserts. Total reaction 
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volume was 10 μL, consisting of 1 μL plasmid DNA, 1X NEB buffer 4, and 6 Units of EcoRI. 
Digestion reactions were incubated at 37°C for 1 hour and were analyzed by electrophoresis in a 
1.2% 0.5X TBE agarose gel containing 100 ng/mL ethidium bromide.  Following electrophoresis 
DNA fragments were visualized under UV illumination.  
  After confirming that plasmids contained inserts, sequencing was performed in an 8.0 μL 
reaction volume containing 3.62 μL Sanger sequencing buffer (.16 M Tris pH 9.0, 3 mM MgCl2, 
4.9% tetramethylene sulfone and 0.001% tween 20), 0.25 μL BigDye® (Applied Biosystems), 
0.08 μL BigDye® dGTP (Applied Biosystems), and 1.31 μM NEB forward or reverse primer, 
with 1 μL of plasmid DNA. Thermocycling parameters include 90 seconds of initial activation at 
96°C, followed by 54 cycles of 15s at 96°C, 15s at 53°C, and 3 minutes at 60°C; this was 
followed by 10 minutes at 60°C with a 10°C hold. Sequencing products were purified using a 
size exclusion with Sephadex G50. Sephadex was first rehydrated with 300 μL Optima water in a 
25-30 MBPP Whatman® Unifilter® 96-well plate and put in fridge overnight. The plate was 
centrifuged at 750g for 2 minutes to remove excess water. Sequencing reactions were added to 
the Sephadex matrix and the plate was centrifuged for 2 minutes at 750g and eluent was 
collected in a nonskirted 96-well plate. Samples were then submitted to the W.M. Keck Center 
for Comparative and Functional Genomics for analysis. Sequence data was gathered using an 
ABI 3730XL DNA Analyzer (Applied Biosystems). Data was analyzed using CodonCode 
Aligner software.  
 
Embryo Collection 
 Female mice were euthanized by CO2 inhalation followed by cervical dislocation. The 
euthanized female was placed supine and the abdomen was sterilized with 70% ethanol to reduce 
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the risk of contamination from maternal hair. The abdominal skin was pinched and a small lateral 
incision was made at the midline with regular surgical scissors. The skin was then pulled apart 
toward the head and tail, exposing the abdomen. The peritoneum was then cut to expose the 
abdominal cavity. Intestines and excess fat obscuring sight of the uterus was pushed aside to 
reveal reproductive organs. The uterine horns were removed by grasping the uterus below the 
oviduct and cutting it free along the mesometrium. Dissected uteri were placed in Dulbecco’s 
phosphate-buffered saline solution (PBS) in a petri dish and placed under a dissecting 
microscope (Shea & Geijsen, 2007). Fatty tissue was first cut away from the uterus. Each 
embryo proper is surrounded by visceral yolk sac, parietal yolk sac and the decidua, appearing as 
“beads on a string” along the uterus (Udan & Dickinson, 2010). Yolk sacs (or “beads”) were 
separated by carefully cutting in between implantation sites (in between beads) and were each 
placed in separate petri dishes containing PBS to avoid further contamination.  The muscle layer 
of each sac was peeled back to expose the decidua. The distal region of the decidua is more 
pointed than the wider ectoplacental cone at  the proximal region (Udan & Dickinson, 2010). The 
apex portion of the decidua was clipped to expose the midventral or distal tip of the enclosed 
embryo. The embryo was then dissected out after carefully tearing decidua apart. Removal of 
residual Reichart’s membrane and ectoplacental cone was carefully performed to ensure 
detachment of all maternal components that could interfere with genotyping. Instruments were 
washed in PBS between embryos. Embryos were placed in 1.7 ml microcentrifuge tubes for 
subsequent DNA extraction and genotyping analysis as previously described.  
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Hormone injection 
 Female mice of each line were superovulated for embryo flushing according to Hogan et 
al.’s (1994) manual on Manipulating the Mouse Embryo. Female mice were picked up by the 
scruff of the neck, ensuring the head was held in place to prevent being bitten. The tail was 
twisted around the little finger to ensure no other movement occurred. Ten IU of equine 
chorionic gonadotropin (eCG) was injected intra-peritoneally, taking care to avoid the diaphragm 
and bladder, waiting briefly before needle withdrawal to ensure solution was injected correctly. 
Ten IU of human chorionic gonadotropin (hCG) was then injected intraperitoneally prior to the 
release of endogenous luteinizing hormone and 48 hours after eCG to induce ovulation. 
Following the hCG injection, a single female was placed with a single male overnight as 
described above. Females were observed for vaginal plugs the next morning, indicating day 
E0.5. If no plug was observed, females were still euthanized on the desired day in order to 
account for potential mating. On E3.5, females were euthanized, their reproductive organs were 
dissected as previously described and placed in a petri dish containing 2% fetal bovine serum 
(FBS) in PBS. Flushing of day E3.5 blastocysts was executed according to Hogan et al.’s manual 
on Manipulating the Mouse Embryo and performed by Dr. Marcello Rubessa (UIUC, Animal 
Sciences, Laboratory of Reproductive Biology and Tissue Engineering). Flushed blastocysts 
were placed in a 96-well plate for whole genome amplification using the Repli-g Mini Kit 
(Qiagen) according to manufacturer’s recommendations. 
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Statistical Methods 
 Pairwise t-tests for comparing litter sizes were performed. Chi-square goodness-of-fit 
was used to test deviation from Mendelian inheritance ratios. A significance threshold of p<0.05 
was used.  
 
2.3 Results and Discussion 
 In cattle, a mutation in NHLRC2 that results in the non-synonymous substitution of a 
highly conserved amino acid residue, p.V311A, is associated with numerous congenital 
abnormalities. Many of these abnormalities are similar to NTDs known to be associated with the 
disruption of neurulation. To further investigate the role of NHLRC2 in development, the 
NHLRC2 locus in mice was targeted for gene-editing.  TALENs were designed to target the 5’ 
end of exon 5 in the mouse NHLRC2 gene. TALEN target sites flanked the orthologous region ‘ 
 
of the known bovine mutation in an effort to model the cattle disease as closely as possible 
(Figure 2.1).  
 Cyagen Biosciences, Inc. was contracted to perform the gene-editing in the FVB mouse 
strain by nuclear injection of TALEN mRNAs into mouse zygotes. Three mice were identified 
following the initial mutation screening (Table A.1). These founder mice were used to generate 
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F1 animals to establish individual breeding lines (Table A.1). Gene-editing was confirmed by 
sequencing NHLRC2 in the founder individuals. Comparison between these sequences and the 
wild-type NHLRC2 sequence showed that all three mutations were deletions within the targeted 
region (Figure 2.1). Deletions of -2 bp, -12 bp, and -19 bp were detected (Figure 2.1). However, 
none of the gene-editing events resulted in the modification or deletion of the codon that is 
mutated in cattle (Figure 2.1) 
 Due to the proximity of the deletions to the 5’ splice junction of exon 5 (Figure 2.1), 
these mutations had an increased probability of altering normal splicing pattern within NHLRC2, 
potentially affecting the protein coding functions and functional properties of NHLRC2 (Ward 
and Cooper 2010). Thus, sequencing of the cDNA for each allele was conducted to confirm each 
mutation’s impact on the encoded NHLRC2 protein. In mice, NHLRC2 is highly expressed 
within the brain, making this tissue ideal for RNA extraction and subsequent cDNA synthesis. 
Whole brains were isolated from a heterozygous mouse corresponding to each mutation and total 
RNA was isolated. Sequence analyses showed no changes in splicing due to these deletions  
 
(Figure 2.2). All sequences generated showed the predicted cDNA sequence based on the 
location of the introduced mutations (Figure 2.2). One sequence indicated that exon 4 of mouse 
NHLRC2 may be alternatively spliced (data not shown). 
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 Translation of the cDNA sequences for each of the gene-edited alleles shows that two of 
the mutations, -2 bp and -19 bp, produce frameshift mutations as would be expected based on the 
number of nucleotides deleted. Although both of these mutations are likely to produce transcripts 
that would be degraded due to nonsense-mediated RNA decay (Hentze & Kulozik, 1999), 
truncation of translation is significantly different for these transcripts (Figure 2.3). For the -2 bp 
mutation, translation of the corresponding mRNA is predicted to extend 43 amino acids beyond  
the mutation (data not shown). In comparison, the -19 bp allele results in the introduction of a 
stop codon in the second codon of the modified exon 5 sequence (Figure 2.3). However, both 
transcripts would encode proteins less than half the normal length of NHLRC2 if translated. In 
contrast to these frameshift mutations, the -12 bp deletion is predicted to produce a protein that is 
missing the four amino acid residues immediately upstream of the substitution associated with 
DD in cattle (Figure 2.3). 
 
 A genotyping assay was successfully developed to facilitate the efficient and accurate 
genotyping of mice produced from experimental matings that were performed to characterize the 
phenotypic effects of these NHLRC2 mutations in each of the three mouse lines. Due to the 
small size of these deletions and the presence of multiple alleles, a genotyping assay based on 
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size differentiation of PCR-amplified fragments was developed (Figure 2.4). PCR primers were 
designed flanking the identified deletion mutations. Detection of PCR amplicons was facilitated 
by the labeling of one primer with the fluorescent dye 6-FAM. The performance of the assay was 
generally robust with no ambiguity in genotype assignment (Figure 2.4). 
 
 
 Initially, matings between wild-type (WT) FVB mice and NHLRC2-edited F1 mice were 
performed to expand the population size. Matings between WT and F1 mice demonstrated that 
progeny heterozygous for each mutation appear phenotypically normal. This was expected based 
on the F1 mice received from Cyagen Biosciences, as well as the recessive inheritance pattern of 
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DD in cattle.  Thirty-one matings between WT and heterozygous mice yielded a total of 267 
offspring. Within each genetic line, average litter size and segregation ratio was examined to 
confirm there was no impact of these mutations in a larger breeding population. Average litter 
size within each line ranged from 8.0 to 9.3 pups per litter (Table 2.1). After performing two 
sample T-tests assuming equal variance, there was no statistical differences in litter size detected 
between lines (p>0.05; Table A.3). Although no matings between WT mice were done, the 
overall average litter size in this population appears similar to that reported in the literature for 
the FVB strain of 9.5 pups/litter (Silver & Barsh, 1995).  
 
Table 2.1. Average Litter Size of WT x Heterozygous Matings 
Mating Type No. of Litters Average Litter Size 
WT x -2 bp 8 9.3 
WT x -12 bp 13 8 
WT x -19 bp 10 8.9 
 
Segregation of alleles for each line in WT x heterozygote matings also appears consistent 
with the expected Mendelian 1:1 inheritance pattern (Table 2.2). There were no indications that 
heterozygosity for these mutations has any impact on survivability as evidenced by relatively 
small deviations from the expected ratios (Table 2.2; Tables A.4). 
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Table 2.2. Summary Chi-square Statistics for Allele Segregation in WT x Heterozygote 
Matings 
 
Genotype 
  
Mating WT Heterozygous X² P Value 
WT x -2 bp 39 35 0.22 0.64 
WT x -12 bp 55 49 0.35 0.55 
WT x -19 bp 43 46 0.10 0.75 
 
 
Heterozygous matings from each line were conducted to observe phenotypic effects 
associated with these mutations for comparison to those seen in cattle with DD. A total of 52 
matings between heterozygous mice yielded 328 offspring. In contrast to the WT x heterozygous 
matings, the litter sizes observed for these matings was significantly smaller with an overall 
average litter size of 6.4 pups versus 8.6 pups (Table 2.3). Comparison of litter sizes between 
lines using two sample T-tests assuming equal variances indicated that the -2 bp line had an 
average litter size that was significantly smaller than the -19 bp line (p<0.05; Table A.3) with a 
trend toward being significantly smaller than the -12 bp line (p<0.10; Table A.3). There was no 
difference in litter size between the -12 bp and -19 bp lines. 
 
Table 2.3. Average Litter Size of Heterozygous x Heterozygous 
Matings 
Mating Type No. of Litters Average Litter Size 
-2 bp x -2 bp 17 5.2 
-12 bp x -12 bp 17 6.7 
-19 bp x -19 bp 12 7.5 
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The underlying basis of the significantly smaller litter sizes was revealed following the 
genotyping of offspring from heterozygous matings. For all three NHLRC2 gene-edited lines, no 
offspring were genotyped as homozygous for any of the introduced mutations (Table 2.4).  
Goodness-of-fit analyses clearly demonstrates that offspring genotype ratios from these matings 
are not consistent with the expected Mendelian segregation (p<0.0001; Table 2.4). As 
confirmation, progeny ratios were tested under a model of lethal inheritance and found not to 
deviate from expected (p>0.05; Table A.4).  
 
Table 2.4. Summary Chi-square Statistics for Allele Segregation in Heterozygote x 
Heterozygote Matings   
 
Genotype 
  
Mating WT Heterozygous 
Homozygous 
Recessive X² P Value 
-2 bp x -2 bp 23 65 0 32.07 <0.001 
-12 bp x -12 bp 41 73 0 38.47 <0.001 
-12 bp x -12 bp (E8.5) 10 15 0 9.00 0.011 
-19 bp x -19 bp  31 59 0 30.07 <0.001 
 
 
The clear absence of homozygous recessive offspring along with decreased litter size 
demonstrated that these mutations were embryonically lethal in mice. Even so, additional 
matings were conducted to characterize the developmental time point where embryonic death 
was occurring. Phenotypes of cattle affected with DD consist of NTD lesions and neural crest 
derived tissue duplications. It is hypothesized that these are the result of improper neural tube 
closure. Thus, the developmental time point of the initiation of neural tube closure in the mouse 
embryo was investigated (E8.5) (J. Gray & Ross, 2011). Five female mice from heterozygous -
12 bp matings with successful plug detection were dissected at E8.5, their embryos were 
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extracted for genotyping. The -12 bp line was chosen due to the potential of this mutation, with 
its deletion of four complete amino acids, having a higher survival rate. Yolk sacs containing no 
embryos were observed with each dissection. The number of yolk sacs exceeded the number of 
live births by 68.7% (11.3 vs. 6.7). The five dissections yielded 26 embryos consisting of 10 WT 
and 15 heterozygous genotypes.  The absence of homozygous recessive genotypes indicated that 
embryonic death was occurring between fertilization and E8.5. However, the number of yolk 
sacs from these E8.5 dissections exceeded the number of live births with this mutation by 68.7% 
(11.3 vs 6.7). This gives indication implantation had occurred but further development of the 
embryo did not occur (Flores, Hildebrandt, Kühl, & Drews, 2014).  Images of seven E8.5 
extracted embryos from a heterozygous -12 mating were captured on a Nikon stereoscopic zoom 
microscope and subsequently genotyped.  Genotyping analysis revealed two heterozygotes and 
five WT embryos. No physical differences between heterozygous and WT E8.5 embryos were 
observed (Figure 2.5).  
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Embryo flushing was performed at E3.5 when an embryo becomes a blastocyst, but 
approximately 24 hours prior to implantation (Fong, et al., 1998). Seven embryos from a -12 
heterozygous mating were obtained. Whole genome amplification of blastocysts followed by 
genotyping by fragment analysis resulted in all heterozygotes. The absence of homozygous 
recessive blastocysts would lead us to theorize that death occurred before implantation, however 
the absence of WT genotypes leads us to conclude that there was occurrence of contamination by 
maternal cells that may have been amplified when performing whole genome amplification. 
 From the discovery that mutations within NHLRC1¸ a family member of NHLRC2, plays 
a role in neurodegeneration within Lafora disease, leads us to believe that mutation within 
Figure 2.5. Comparison of microscopic images of E8.5 embryos from a 
-12 bp heterozygous mating after the initiation of neural tube closure. 
Panel A represents a heterozygous embryo. Panel B-D represent WT 
embryos.  
    
A B 
C D 
41 
 
NHLRC2 also effects the p53 mediated cell death pathway, leading to an increase in proapoptosis 
(Upadhyay, et al., 2015). Apoptosis, or programmed cell death, plays an important role in overall 
mammalian development, also playing a key role during central nervous system development, 
occurring mainly during the bending and fusion of the neural folds, neural tube remodeling and 
migration of neural crest cells (De Zio, Giunta, Corvaro, Ferraro, & Cecconi, 2005; Massa, et al., 
2009). Proapoptosis, or excessive cell death, would result in an insufficient amount of cells 
needed to complete neurulation, specifically neural tube closure, resulting in NTDs. A lack of 
apoptosis has also been shown to be correlated with NTDS, showing the importance of the 
required amount of neurulation and successful neurulation (Massa, et al., 2009). DD affected 
calves with polymelia have extra limbs from the CNS region, suggesting that extra limbs were 
derived from neural crest cells that may have escaped during proapoptotic events during 
neurulation. Affected individuals also display lesions from NTDs, also leading us to theorize 
there is proapoptotic factors during neurulation that contribute to the development of lesions.     
 
2.4 Conclusion  
We have examined the role of NHLRC2 has in mammalian development by generating a 
mouse model deficient in this gene with varying affects. Heterozygous mice appeared 
phenotypically normal and the absence of homozygous recessive offspring suggests embryonic 
lethality. Dissection of E8.5 embryos and the observance of empty yolk sacs suggests death 
occurs after implantation but before the initiation the closure of the neural tube. It is suggested 
that like its family member NHLRC1, mutations in NHLRC2 results in proapoptotic events 
leading to incomplete neurulation. This study showed that mutation within the NHLRC2 gene in 
the mouse has more of an impact than cattle, as expected due to the subtle amino acid 
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substitution in bovine, but enhances the theory that this gene plays an important role in 
mammalian development.  
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Appendix A: Appendix Tables 
Table A.1 Gene-Edited Founder FVB Mice Received From Cyagen 
   
 
      
 Gene-edited Founder Mice From Cyagen  
Mouse ID Sex Genotype Generation DOB 
#70 F -19 bp heterozygous F0 8-Apr-14 
#48 M -2 bp heterozygous F0 8-Apr-14 
#60 M -12 bp heterozygous F0 8-Apr-14 
#7 F -2 bp heterozygous F1 (#48 x WT) 24-Jun-14 
#2 M -2 bp heterozygous F1 (#48 x WT) 24-Jun-14 
#4 M -2 bp heterozygous F1 (#48 x WT) 24-Jun-14 
#3 F -12 bp heterozygous F1 (#60 x WT) 27-Jun-14 
#14 F -12 bp heterozygous F1 (#60 x WT) 27-Jun-14 
#5 M -12 bp heterozygous F1 (#60 x WT) 27-Jun-14 
#8 M -12 bp heterozygous F1 (#60 x WT) 27-Jun-14 
#7 F -19 bp heterozygous F1 (#70 x WT) 27-Jun-14 
#6 M -19 bp heterozygous F1 (#70 x WT) 27-Jun-14 
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Table A.2 Genotype and Sex Distribution of Litters by Mating Type 
 
WT x -19 bp Heterozygous 
 
Genotype (Dead at Birth) 
 
Sex 
  Dam WT Heterozygous   M F Litter Size DOB 
#9 7(0) 3(1) 
 
4 6 11 25-Jan-15 
#14 3(0) 4(0) 
 
6 1 7 25-Jan-15 
#10 7(0) 3(1) 
 
5 5 11 31-Jan-15 
#10 7(0) 4(0) 
 
5 6 11 3-Apr-15 
#53 3(1) 5(0) 
 
1 7 9 11-May-15 
#33 3(0) 5(0) 
 
4 4 8 18-Jun-15 
#53 4(0) 3(0) 
 
3 4 7 6-Jul-15 
#162 4(0) 5(1)   2 7 10 6-Jul-15 
Total 38(1) 32(3) 
 
30 40 74 
 
        WT x -12 bp Heterozygous 
 
Genotype (Dead at Birth) 
 
Sex 
  Dam WT Heterozygous   M F Litter Size DOB 
#6 7(0) 4(0) 
 
4 3 11 31-Jan-15 
#22 6(0) 3(0) 
 
4 3 9 3-Feb-15 
#23 4(0) 3(1) 
 
2 5 8 3-Feb-15 
#21 3(1) 3(0) 
 
2 5 7 8-Feb-15 
#7 5(0) 3(0) 
 
4 4 8 26-Feb-15 
#38 3(0) 4(0) 
 
2 5 7 18-Jun-15 
#204 2(0) 3(0) 
 
2 3 5 18-Sep-15 
#375 5(0) 2(0) 
 
3 4 7 21-Sep-15 
#363 5(0) 4(1) 
 
6 3 10 21-Sep-15 
#373 2(0) 7(0) 
 
4 5 9 21-Sep-15 
#51 0(4) 0(5) 
 
0 0 9 21-Sep-15 
#399 4(0) 4(0) 
 
7 1 8 27-Dec-15 
#403 4(0) 2(0) 
 
3 3 6 28-Dec-15 
Total 50(5) 42(7)   43 44 104   
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Table A.2 (Cont.) 
 
     WT x -2 bp Heterozygous 
  Genotype (Dead at Birth)   Sex     
Dam WT Heterozygous   M F Litter Size DOB 
#17 4(0) 4(0) 
 
4 4 8 27-Jan-15 
#19 4(0) 5(0) 
 
6 3 9 27-Jan-15 
#20 1(1) 5(2) 
 
2 4 9 27-Jan-15 
#24 3(0) 4(0) 
 
4 3 7 8-Jul-15 
#23 6(1) 1(0) 
 
4 3 8 11-Jul-15 
#199 4(0) 3(1) 
 
3 4 8 11-Jul-15 
#291 5(1) 3(2) 
 
2 6 11 21-Sep-15 
#292 4(1) 2(2) 
 
4 2 9 21-Sep-15 
#344 4(0) 5(0) 
 
1 8 9 21-Sep-15 
#346 4(0) 7(0)   4 7 11 21-Sep-15 
Total 39(4) 39(7) 
 
34 44 89 
 
        -19 bp Heterozygous x -19 Heterozygous 
 
Genotype (Dead at Birth) 
 
Sex 
  Dam WT Heterozygous   M F Litter Size DOB 
#18 1(0) 4(1) 
 
1 4 6 30-Mar-15 
#45 5(0) 6(0) 
 
3 8 11 3-May-15 
#27 2(0) 6(2) 
 
4 4 10 4-May-15 
#43 3(0) 5(0) 
 
3 5 8 7-May-15 
#29 0(3) 0(1) 
 
0 0 4 11-May-15 
#18 4(1) 3(1) 
 
6 1 9 18-May-15 
#130 2(0) 7(0) 
 
6 3 9 19-Jun-15 
#129 0(1) 0(2) 
 
0 0 3 21-Jun-15 
#27 2(0) 5(1) 
 
3 4 8 10-Jul-15 
#188 3(0) 5(0) 
 
4 4 8 8-Jul-15 
#468 1(0) 9(0) 
 
6 4 10 14-Feb-16 
#346 0(3) 0(1) 
 
0 0 4 17-Feb-16 
Total 23(8) 50(9)   36 37 90   
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Table A.2 (Cont.) 
 
     -12 bp Heterozygous x -12 bp Heterozygous 
 
Genotype (Dead at Birth) 
 
Sex 
  Dam WT Heterozygous   M F Litter Size DOB 
#8 0(2) 2(1) 
 
2 0 5 31-Jan-15 
#51 2(0) 3(0) 
 
2 3 5 6-Apr-15 
#116 1(0) 1(0) 
 
1 1 2 14-Apr-15 
#114 2(0) 6(0) 
 
3 5 8 15-Apr-15 
#122 4(0) 5(0) 
 
4 5 9 4-May-15 
#50 1(0) 0(6) 
 
0 1 7 13-May-15 
#54 3(0) 2(0) 
 
2 3 5 13-May-15 
#51 1(0) 4(0) 
 
0 5 5 21-May-15 
#119 4(0) 4(0) 
 
5 3 8 21-May-15 
#50 1(0) 3(0) 
 
3 1 4 6-Jul-15 
#51 2(0) 4(1) 
 
3 3 7 6-Jul-15 
#54 2(1) 3(0) 
 
2 3 6 17-Jul-15 
#238 1(0) 3(0) 
 
2 2 4 17-Jul-15 
#253 3(0) 4(0) 
 
4 3 7 9-Aug-15 
#206 6(0) 5(0) 
 
6 5 11 22-Aug-15 
#253 2(0) 5(3) 
 
4 2 10 20-Sep-15 
#257 3(0) 8(0)   9 2 11 23-Sep-15 
Total 38(3) 62(11) 
 
52 47 114 
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Table A.2 (Cont.) 
 
     -2 bp Heterozygous x -2 bp Heterozygous 
 
Genotype (Dead at Birth) 
 
Sex 
  Dam WT Heterozygous   M F Litter Size DOB 
#12 0(0) 0(2) 
 
0 0 2 3-Feb-15 
#25 0(0) 8(0) 
 
5 3 8 1-Apr-15 
#47 1(0) 2(0) 
 
0 3 3 11-May-15 
#37 2(0) 2(0) 
 
2 2 4 13-May-15 
#25 1(0) 4(0) 
 
1 4 5 16-May-15 
#135 2(0) 3(2) 
 
3 2 7 19-Jun-15 
#148 0(0) 3(0) 
 
2 1 3 7-Jul-15 
#149 2(0) 6(0) 
 
4 4 8 11-Jul-15 
#326 3(0) 4(0) 
 
4 3 7 16-Sep-15 
#328 1(0) 4(0) 
 
1 4 5 17-Sep-15 
#329 1(0) 4(1) 
 
4 1 6 17-Sep-15 
#298 5(0) 4(0) 
 
8 1 9 17-Sep-15 
#325 0(0) 1(1) 
 
1 0 2 23-Sep-15 
#327 0(0) 6(0) 
 
3 3 6 14-Feb-16 
#500 2(0) 4(0) 
 
3 3 6 16-Feb-16 
#329 0(1) 0(0) 
 
0 0 1 16-Feb-16 
#329 2(0) 4(0) 
 
1 5 6 23-Mar-16 
Total 22(1) 61(4)   42 39 88   
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  Table A.3 Two Sample T-Tests Assuming Equal Variance Comparing Litter Sizes by Mating 
Type 
  -19 bp x -19 bp -12 bp x -12 bp 
Mean 7.5 6.7 
Variance 7 6.6 
Observations 12 17 
Pooled Variance 6.8 
 Hypothesized Mean Difference 0 
 df 27 
 t Stat 0.81 
 P(T<=t) two-tail 0.42 
 t Critical two-tail 2.05   
     
  -19 bp x -19 bp  -2 bp x -2 bp 
Mean 7.5 5.2 
Variance 7 5.5 
Observations 12 17 
Pooled Variance 6.1 
 Hypothesized Mean Difference 0 
 df 27 
 t Stat 2.49 
 P(T<=t) two-tail 0.02 
 t Critical two-tail 2.05   
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Table A.3 (cont.) 
    
  -12 bp x -12 bp -2 bp x -2 bp 
Mean 6.7 5.2 
Variance 6.6 5.5 
Observations 17 17 
Pooled Variance 6.1 
 Hypothesized Mean Difference 0 
 df 32 
 t Stat 1.81 
 P(T<=t) two-tail 0.08 
 t Critical two-tail 2.04   
     
  WT x -19 bp WT x -12 bp 
Mean 8.9 8.0 
Variance 1.7 2.7 
Observations 10.0 13.0 
Pooled Variance 2.2 
 Hypothesized Mean Difference 0 
 df 21 
 t Stat 1.43 
 P(T<=t) two-tail 0.17 
 t Critical two-tail 2.08   
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Table A.3 (cont.) 
    
  WT x -19 bp WT x -2 bp 
Mean 8.9 9.3 
Variance 1.7 3.1 
Observations 10 8 
Pooled Variance 2.3 
 Hypothesized Mean Difference 0 
 df 16 
 t Stat -0.49 
 P(T<=t) two-tail 0.63 
 t Critical two-tail 2.12   
   t-Test: Two-Sample Assuming Equal Variances 
  WT x -12 bp WT x -2 bp 
Mean 8.0 9.3 
Variance 2.7 3.1 
Observations 13 8 
Pooled Variance 2.8 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -1.66 
 P(T<=t) two-tail 0.11 
 t Critical two-tail 2.09   
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Appendix Table A.4 Chi Square Analysis by Mating Type 
         
WT x -19 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 43.00 0.48 44.50 0.50 -1.50 2.25 0.05 0.75 
Heterozygous 46.00 0.52 44.50 0.50 1.50 2.25 0.05 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 89.00 
 
89.00 
  
Chi² 0.10 
                   
WT x -12 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 55.00 0.53 52.00 0.50 3.00 9.00 0.17 0.55 
Heterozygous 49.00 0.47 52.00 0.50 -3.00 9.00 0.17 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 104.00 
 
104.00 
  
Chi² 0.35 
                   
WT x -2 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 39.00 0.53 37.00 0.50 2.00 4.00 0.11 0.64 
Heterozygous 35.00 0.47 37.00 0.50 -2.00 4.00 0.11 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 74.00 
 
74.00 
  
Chi² 0.22 
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Table A.4 (cont.) 
                 
-19 bp x -19 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 31.00 0.34 22.50 0.25 8.50 72.25 3.21 <0.01 
Heterozygous 59.00 0.66 45.00 0.50 14.00 196.00 4.36 
 Homozygous Recessive 0.00 0.00 22.50 0.25 -22.50 506.25 22.50   
Total 90.00 
 
90.00 
  
Chi² 30.07 
                   
-12 bp x -12 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 41.00 0.36 28.50 0.25 12.50 156.25 5.48 <0.01 
Heterozygous 73.00 0.64 57.00 0.50 16.00 256.00 4.49 
 Homozygous Recessive 0.00 0.00 28.50 0.25 -28.50 812.25 28.50   
Total 114.00 
 
114.00 
  
Chi² 38.47 
                   
-12 bp x -12 bp (E8.5) 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 10.00 0.40 6.25 0.25 3.75 14.06 2.25 0.01 
Heterozygous 15.00 0.60 12.50 0.50 2.50 6.25 0.50 
 Homozygous Recessive 0.00 0.00 6.25 0.25 -6.25 39.06 6.25   
Total 25.00 
 
25.00 
  
Chi² 9.00 
                   
-2 bp x -2 bp  
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 23.00 0.26 22.00 0.25 1.00 1.00 0.05 <0.01 
Heterozygous 65.00 0.74 44.00 0.50 21.00 441.00 10.02 
 Homozygous Recessive 0.00 0.00 22.00 0.25 -22.00 484.00 22.00   
Total 88.00 
 
88.00 
  
Chi² 32.07 
  
69 
 
 
Table A.5 Chi Square Analysis for Lethal Inheritance by Mating Type 
 
   -19 bp x -19 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 31.00 0.34 29.70 0.33 1.30 1.69 0.06 0.78 
Heterozygous 59.00 0.66 60.30 0.67 1.30 1.69 0.03 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 90.00 
 
90.00 
  
Chi² 0.08 
 
         -12 bp x -12 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 41.00 0.36 37.62 0.33 3.38 11.42 0.30 0.50 
Heterozygous 73.00 0.64 76.38 0.67 3.38 11.42 0.15 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 114.00 
 
114.00 
  
Chi² 0.45 
 
         -12 bp x -12 bp (E8.5) 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 10.00 0.40 8.25 0.33 1.75 3.06 0.37 0.46 
Heterozygous 15.00 0.60 16.75 0.67 1.75 3.06 0.18 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 25.00 
 
25.00 
  
Chi² 0.55 
 
         -2 bp x -2 bp 
Genotype Observed % Expected % O-E (O-E)² (O-E)²/E P Value 
WT 23.00 0.26 29.04 0.33 6.04 36.48 1.26 0.17 
Heterozygous 65.00 0.74 58.96 0.67 6.04 36.48 0.62 
 Homozygous Recessive 0.00 0.00 0.00 0.00 0.00 0.00 0.00   
Total 88.00 
 
88.00 
  
Chi² 1.88 
  
